As payers and providers consolidate and use their market share to influence negotiations with manufacturers, what can pharma do to protect their business and capture value for their products? This month, NAI President Rita E. Numerof, Ph.D., clarifies the serious implications associated with this trend in her Industry Insights column with eyeforpharma, Implications of Massive Healthcare Consolidation for Pharma, published August 12, 2013.